Professional Documents
Culture Documents
CESSATION
The 5 A’s advance approach is not only summarized but goal oriented way of studying and
giving the guidelines regarding the use of tobacco and their negative aspects on patients and
healthy people. It gives the guideline to the patients to give up the use of tobacco. This cessation
don’t ask the patients to quit smoking suddenly but to give it up gradually. Therefore this famous
5 A’s cessation should not be applied to the patients in very tough way and rigid and strict
manner.
Their should be leniency in helping the patient in quieting smoking. And this involves the whole
staff of the patients which can give him courage to spend life without smoking. Doctors ,
Pharmacist and other staff should make sure that the patient is ready for giving up the use of
tobacco.
i)Ask:
This involves asking the questions to the patients regarding their daily use and consumption of
tobacco as part of their vital signs like body temperature, blood pressure etc. In this the doctor
should know about the current and past routine of smoking.
ii)Advice:
In this session the doctor or the pharmacist ask the patient to give up the use of tobacco in the
manner of advise . And the quiting should be in a very clear , strong and personalized manner.
Persuade every tobacco user to quit it Expect ambivalence. Be willing to listen non-judgmentally
to his/her concerns about quitting tobacco use.
iii)Assess:
In this session the doctor or the pharmacist determine that the patient is either ready to quit
tobacco or just forcibly doing so. How much he or she is interested in quit of tobacco.Assess
how ready the patient currently is to quit tobacco use. Readiness rulers (i.e., “On a scale of 1 to
10, where 10 is very ready
Free telephone counseling through the Maryland Quitline with an easy referral through our Fax
to Assist program
iv)Assest
For those who have successfully quit using tobacco, you can Assist by affirming their success to
support self-efficacy, and discussing any challenges to staying quit and methods to prevent
relapse.
v)Arrange:
Follow-up is most helpful to do it within the first weeks of a quit date and can be either in person
or via telephone. During this call encourage the individual to remain quit. Discuss any obstacles
and how to overcome them. Congratulate success for those who have been able to quit. For those
who continue to use tobacco, repeated use of the 5 A’s and 5 R’s is important for supporting
motivational changes over time to move toward Action for quitting tobacco.
Some providers and settings prefer to use abbreviated forms of the 5 A’s model, such as Ask
Advise Refer(link is external), which focuses on referring patients to national tobacco quitlines
for assistance.[6]
4. TRANS THEORETICAL MODELS (TTM)
James Prochaska and Carlo DiClemente was recongnized the stages of change model.
TMM provide a structure for considerate or prevailingusing human intended behavior
modification. It has 3 establishing constructs of the model
1. The Stages of change.
2. The processes of change.
3. The context of change.
STAGES OF CHANGE
According to TMM, the behavior change can conceptualized as a series of five sequential stages
STAGE A tobacco consumer in this step……..
CONTEXT OF CHANGE
The context of change contains areas of effective that accompaniment ormeasurevia the stages of
change.
CONTEXT DESCRIPTION
Current life situation Current environment ( external or internal)
check i.e. level of anxiety or financial
Belief and Attitude Belief how change occur and what’s need for
change
Interpersonal Relationships Interact with other individuals
Social system Family system or social system or barriers to
change
Enduring personal Characteristics Personality Characteristics [7]
A) VARENICLINE
Varenicline decreases the nicotine withdrawl symptoms by inhibiting the binding of nicotine to
the receptor that activates the increasing effect s of nicotine which automatically increases the
nicotine dependence by this aspect varenicline is considered to reduce cigarette smoking.[14]
Safety
This drug can be used by chronic obstructive pulmonary disease (COPD ) patients safely
The main side effects include sleeping disorders, insomnia and nausea. Nausea can be reduced if
drug is used with fool or full glass of water.
Dosing
Smokers are suggested to stop smoking after one week of starting the vareniclin
The given dose is
0.5 mg daily For 3 days
0.5 mg bid daily For 4 days
1 mg bid daily For remaining 12 week of course
Evidence shows no psychiatric disorders or CVS disorders after using this drug than other FDA
approved smoking cessation drugs but it is suggested that if smoker using this drug shows any
symptoms like agitation ,behavioral changes ,depressed mood or suicidal attempt must stop the
drug and contact with consultant.[15]
B) BUPROPION
Bupropion works by increasing CNS noradrenergic and dopaminergic release
Safety
This drug is safe to use for stable patients of CVD and COPD. The side effects which are most
common are insomnia, headache, agitation and dry mouth
Dose
The common formulation used is sustained release bupropion. This drug is started before a week
of quitting date to attain steady state blood level it takes 5-7 days
The recommended course is of 12 weeks initial dose is 150 mg/day for 3 days and then 150 mg
bid thereafter. [16]
6. NON-PHARMACOLOGICAL TREATMENT FOR SMOKING
CESSATION
Community Pharmacist play a vital role in the non pharmacological treatment for smoking
cessation.Pharmacist help smokers to quit smoking by giving these non pharmacological
therapies,These non-pharmacological intervention for smoking cessation may include patient
education and advise, behavioral therapy which include both individual and group counseling,
self improvement programs and telephone counseling.[17]
ADVISE AND EDUCATION
Community pharmacist provide education about the smoking cessation .They can provide
information about the health illness by taking cigarettes and health benefits of quitting smoking.
They educate the patient how to quit smoking.[18]
Life style modification to minimize the stress and to improve quality of life by beginning
exercise which can improve the potential to quit smoking and prevent relapse.
Prevent contemplation like having one cigarette won’t hurt, one cigarette ordinarily
prompts some more.
Identify feeling or activities that raise your craving to smoke.[19][20]
SELF IMPROVEMENT PROGRAMS
For smoking cessation self improvement program mainly comprise of electronic or printed
material. To increase motivation to stop smoking community pharmacist may provide these
printed materials to the patient and also give information on how to achieve this objective.
The self improvement programs have various advantages which may includes
These self improvement programs are comparatively cheap.
For recurrent quit endeavor these written materials which are given to the patients can be
used again.[17]
TELEPHONE COUNSELING
Community pharmacist can also talk to the patient on telephone for counseling . Telephone
counseling can give information to the patient and provide support to the smokers.Telephone
counseling a well accepted methodology for the treatment of smoking cessation comprise of
both receptive(it means smoker first call to hotline) and proactive ( it means instructor start call
to smokers) approaches. Calls may utilize a format which is an organized problem solving or
give more personal tailored response. The time span of telephone contact of counselor and
smoker is comparatively short extending from 5 to 20 minutes.[21]
CONGINITIVE BEHAVIORAL APPROACH ES
Another non pharmacological treatment for smoking cessation may include conginitive (learning
how to reduce and how to cope with negative state of mind),behavioral (change the habit to stop
or to avoid the smoking) and motivational(listening why the smoking is not essential for
us).These all information provided by the pharmacist to help the smoker to quit smoking easily.
These approaches may include both individual and group counseling. Group councelling may
involves lectures and group meetings in which community pharmacist or other health care
providers provides suggestions for preventing relapse but their cost can vary.
Concelling that is provided to the patient or smoker and bilateral telephone counseling are very
effectual than simply giving the self improvement materials and education.
Non pharmacological treatment are effective and give support to the patient who are attempting
to stop smoking.[22][23]
7. ELECTRONIC CIGARETTES
Tobacco use among adults and adolescents remains prevalent in the United States. Many
smokers wish to quit, but a number of cessation attempts are usually necessary to overcome
tobacco use. Tobacco use should be treated as a chronic condition, and the community
pharmacist must assess the patient’s readiness to quit prior to initiating pharmacotherapy.
Behavioral interventions should be utilized in the patient who is not ready to quit, and these
should be coupled with an appropriate pharmacotherapy selection once the patient is ready to
quit. Community pharmacists are well positioned to perform interventions with patients who use
tobacco.
Electronic cigarettes, also known as smokeless cigarettes, e-cigarettes, or e-cigs, are an
alternative method of consuming nicotine, the addictive chemical found in tobacco.
Manufacturers often design e-cigarettes to look like regular cigarettes, but they contain no
tobacco and don't require a match -- or any flame at all.
An e-cigarette is a battery-powered device that converts liquid nicotine into a mist, or vapor, that
the user inhales. There's no fire, no ash and no smoky smell. E-cigarettes do not contain all of the
harmful chemicals associated with smoking tobacco cigarettes, such as carbon monoxide and tar.
Manufacturers and satisfied customers say the e-cigarette is a healthier alternative to tobacco
cigarettes, which cause millions of deaths every year. Some users say e-cigs have helped reduce
their "smoker's cough," sharpened their senses of taste and smell, and even improved their sleep
Electronic cigarettes (e-cigarettes) are battery-operated devices containing nicotine and other
substances (e.g., propylene glycol). E-cigarettes are growing in popularity: There were 2.4
million users in middle school and high school in 2014, and 12.6% of adult smokers have tried
them. Those most likely to use e-cigarettes are young adults (age 18-24 years) and current
smokers who attempted to quit in the past year. These devices have provoked safety concerns,
and their role in smoking cessation is heavily debated. E-cigarettes have been found to emit toxic
compounds, such as formaldehyde, via breakdown of cartridge substances (e.g., propylene
glycol, glycerin). Although they are thought to emit significantly lower levels of carcinogens
than tobacco cigarettes, they have been shown to emit toxic chemicals (e.g., diethylene glycol)
and carcinogenic impurities (e.g., N-nitrosonornicotine). Diethylene glycol, a flavoring agent
previously used to manufacture popcorn, is associated with the development of bronchiolitis
obliterans (“popcorn lung”), a severe condition involving permanent loss of lung function. study
of 51 e-cigarette flavoring juices (e-juices) found diethylene glycol in 76% of e-juices, raising
concerns over health risks different from those of combustible cigarettes. E-cigarette flavorings
have been identified as a potential harm by the American Lung Association.
The pharmacist should assess the patient’s use of e-cigarettes in place of combustible cigarettes
or as a cessation aid. Despite the lack of consistent evidence for e-cigarettes as a cessation aid,
physicians support their use 61% of the time when asked by patients who are interested in
quitting. Based on inconsistent evidence and the potential for emerging health risks, e-cigarettes
are not an appropriate cessation tool for most patients. Their use should be restricted to patients
who will not attempt any other cessation method, and patients should be apprised of the potential
harms.
As the most accessible healthcare providers, community pharmacists can support patients’
attempts to quit smoking. A systematic review of tobacco interventions by pharmacists
demonstrated that pharmacists can deliver smoking-cessation services and suggested they are
effective in helping patients successfully quit. Community pharmacists who provide smoking-
cessation services have cessation rates similar to those of other healthcare professionals. The
pharmacist should select the most appropriate therapy for the patient and counsel the patient on
how to use it correctly. It is estimated that a smoker requires eight to 11 cessation attempts, and a
Gallup poll reported that smokers average 6.1 quit attempts before achieving success. However,
recent literature indicates that the average may be as high as 30 quit attempts, noting that
previous figures may be underestimated because of the exclusion of smokers facing significant
challenges in quitting and limitations in smokers’ ability to recall lifetime quit attempts.
Pharmacists should be encouraged to perform interventions when counseling patients who are
picking up medications; even a brief intervention (3 minutes) increases patient interest and
success in quitting. Counseling interventions have been associated with greater cessation success
as the number of interventions increases. Community pharmacists should be supportive of
patients who are unsuccessful, identifying barriers and adjusting pharmacotherapy. It should be
expected that smokers will require multiple attempts, and community pharmacists should assist
in both behavioral counseling and pharmacotherapy management. All patients should be referred
to 1-800-QUIT-NOW for additional support. Pharmacists can also use the quizzes at
Smokefree.gov (e.g., a quiz on identifying stressors and how to manage them; a withdrawal quiz
to determine the degree of symptoms; and a nicotine-addiction quiz that assesses how much the
patient relies on nicotine and ways to curb cravings).
REFERENCES
1. Community pharmacy personnel interventions for smoking cessation (Review) , The
Cochrane Collaboration. Published by John Wiley & Sons, Ltd.The Cochrane Library
2008, Issue 4.
2. Silagy 2004 Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement
therapy for smoking cessation. Cochrane Database of Systematic Reviews 2004, Issue
3. Lancaster 2000 Lancaster T, Silagy C, Fowler G. Training health professionals in
smoking cessation. Cochrane Database of Systematic Reviews 2000, Issue 3.
4. Raw M, McNeill A, West R(1998) Smoking cessation guidelines for health
professionals. (1998) volume 55, issue 12
5. Your pharmacist's role in smoking cessation, health, health tips, © The Jean Coutu
Group (PJC) Inc.2018.
6. Maryland tobaccos resource center 2008 pg 6 ( Rollnick, Miller and Butler)
7. James O. Prochaska, Wayne F. Velicer: online pdf for trans theoretical model for
behavior change: September 1997 Volume: 12 issue: 1, page(s): 38-48
8. Mathers CD, Loncar D. Projections of global mortality and burden of disease from
2002 to 2030. PLoS Med 2006 Nov; 3(11): e442
9. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic
medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA
2000;284:1689-95.
10. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking
cessation: an overview and network meta-analysis. Cochrane Database Syst Rev
2013;5:0.
11. Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after
smoking lapses promotes recovery of abstinence. Addiction. 2012 Jan 26. [Medline]
12. Etter JF, Huguelet P, Perneger TV, Cornuz J. Nicotine gum treatment before smoking
cessation: a randomized trial. Arch Intern Med. 2009 Jun 8. 169(11):1028-34
13. Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, et al. A
randomized placebo-controlled clinical trial of 5 smoking cessation
pharmacotherapies. Arch Gen Psychiatry. 2009 Nov. 66(11):1253-62. [Medline].
14. Hays JT, Ebbert JO. Varenicline for tobacco dependence. N Engl J Med 2008;
359:2018.
15. Hajek P, McRobbie HJ, Myers KE, et al. Use of varenicline for 4 weeks before
quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Arch Intern Med 2011; 171:770
16. https://www.uptodate.com/contents/pharmacotherapy-for-smoking-cessation-in-adults
1 line pharmacotherapy for smoking cessation
17. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane
Database Syst Rev. 2005;(3):CD00111.
18. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence:
Clinical Practice Guideline. Rockville, MD: US Dept of Health and Human Services,
Public Health Service.
19. Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst 1999; 91:1365.
20. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help
people stop smoking: findings from the Cochrane Library. BMJ 2000; 321:355.
21. Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for
smoking cessation in women: a randomized controlled trial. Arch Intern Med.
1999;159:1229 –1234.
22. Curry SJ. Self-help interventions for smoking cessation. J Consult Clin Psychol.
1993;61:790 – 803
23. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic
acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for
smoking cessation: a randomized controlled trial. JAMA 2006; 296:47.